Brief

Eiger Biopharmaceuticals (EIGR) Gets a Buy Rating from Wedbush

Wedbush analyst Liana Moussatos maintained a Buy rating on Eiger Biopharmaceuticals (EIGR) today and set a price target of $35. The company’s shares …

RBC Capital Reaffirms Their Sell Rating on Deutsche Bank AG (DB)

RBC Capital analyst Anke Reingen maintained a Sell rating on Deutsche Bank AG (DB) yesterday and set a price target of $7.50.

J.P. Morgan Keeps a Sell Rating on Continental Aktiengesellschaft (CTTAF)

In a report released yesterday, Jose Asumendi from J.P.

Analysts’ Opinions Are Mixed on These Financial Stocks: Deutsche Bank AG (DB) and Societe Generale (OtherSCGLY)

Analysts have been eager to weigh in on the Financial sector with new ratings on Deutsche Bank AG (DB) and Societe Generale (SCGLY). …

Roth Capital Thinks The Meet Group Inc’s Stock is Going to Recover

Roth Capital analyst Darren Aftahi maintained a Buy rating on The Meet Group Inc (MEET) on June 16 and set a price target …

RegenXBio (RGNX) Gets a Buy Rating from Chardan Capital

Chardan Capital analyst Gbola Amusa reiterated a Buy rating on RegenXBio (RGNX) today and set a price target of $150. The company’s shares …

Synovus (SNV) Gets a Hold Rating from Stephens

In a report released today, Tyler Stafford from Stephens maintained a Hold rating on Synovus (SNV), with a price target of $40. The …

Williams Capital Thinks SM Energy’s Stock is Going to Recover

Williams Capital analyst Gabriele Sorbara reiterated a Buy rating on SM Energy (SM) today and set a price target of $25. The company’s …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts